- Home
- CTW vs SWKH Comparison
CTW vs SWKH Comparison
Compare CTW & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTW
- SWKH
- Stock Information
- Founded
- CTW 2013
- SWKH 1996
- Country
- CTW Japan
- SWKH United States
- Employees
- CTW N/A
- SWKH N/A
- Industry
- CTW EDP Services
- SWKH Diversified Financial Services
- Sector
- CTW Technology
- SWKH Finance
- Exchange
- CTW Nasdaq
- SWKH Nasdaq
- Market Cap
- CTW 171.4M
- SWKH 179.1M
- IPO Year
- CTW 2025
- SWKH 1999
- Fundamental
- Price
- CTW $1.87
- SWKH $14.68
- Analyst Decision
- CTW
- SWKH Strong Buy
- Analyst Count
- CTW 0
- SWKH 1
- Target Price
- CTW N/A
- SWKH $18.00
- AVG Volume (30 Days)
- CTW 924.2K
- SWKH 12.0K
- Earning Date
- CTW 01-01-0001
- SWKH 08-14-2025
- Dividend Yield
- CTW N/A
- SWKH N/A
- EPS Growth
- CTW N/A
- SWKH 51.50
- EPS
- CTW N/A
- SWKH 1.41
- Revenue
- CTW $76,194,020.00
- SWKH $34,906,000.00
- Revenue This Year
- CTW N/A
- SWKH $52.93
- Revenue Next Year
- CTW N/A
- SWKH N/A
- P/E Ratio
- CTW $44.00
- SWKH $10.36
- Revenue Growth
- CTW 8.71
- SWKH 18.02
- 52 Week Low
- CTW $1.84
- SWKH $12.00
- 52 Week High
- CTW $4.88
- SWKH $16.24
- Technical
- Relative Strength Index (RSI)
- CTW N/A
- SWKH 42.54
- Support Level
- CTW N/A
- SWKH $14.53
- Resistance Level
- CTW N/A
- SWKH $14.88
- Average True Range (ATR)
- CTW 0.00
- SWKH 0.20
- MACD
- CTW 0.00
- SWKH -0.07
- Stochastic Oscillator
- CTW 0.00
- SWKH 19.33
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.